Inventor · London, GB

Sergio Quezada

20Patents
7h-index
20Co-inventors
65Inventor score

Filing activity: Apr 24, 2006 → Feb 5, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8236304B2 Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate CD4+ and CD8+ T cell immunity Chemistry; Metallurgy 27 Active
US8709417B2 Combination immunotherapy for the treatment of cancer Chemistry; Metallurgy 26 Active
US8465740B2 Regulatory T cell mediator proteins and uses thereof Chemistry; Metallurgy 23 Active
US9375475B2 Combination immunotherapy for the treatment of cancer Chemistry; Metallurgy 17 Active
US10752691B2 Anti-CD25 antibody agents Chemistry; Metallurgy 10 Active
US10738125B2 Anti-CD25 antibody agents Chemistry; Metallurgy 10 Active
US10745485B2 Anti-CD25 antibody agents Chemistry; Metallurgy 10 Active
US10023637B2 Combination immunotherapy for the treatment of cancer Chemistry; Metallurgy 5 Active
US10167337B2 Combination immunotherapy for the treatment of cancer Chemistry; Metallurgy 3 Active
US11098121B2 “Immune checkpoint intervention” in cancer Chemistry; Metallurgy 2 Active
US11802160B2 Anti-CD25 antibody agents Chemistry; Metallurgy 0 Active
US8097249B2 Use of PD-L3 proteins and PD-L3 specific antibodies or antibody fragments to regulate D4+ and CD8+ T cell immunity General 0 Revoked
US11851494B2 Anti-CD25 for tumour specific cell depletion Chemistry; Metallurgy 0 Active
US11873341B2 Anti-CD25 for tumour specific cell depletion Chemistry; Metallurgy 0 Active
US11814434B2 Anti-CD25 for tumour specific cell depletion Chemistry; Metallurgy 0 Active
US11802161B2 Anti-CD25 for tumour specific cell depletion Chemistry; Metallurgy 0 Active
US11697688B2 Anti-CD25 for tumour specific cell depletion Chemistry; Metallurgy 0 Active
US11879014B2 Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody Chemistry; Metallurgy 0 Active
US11787866B2 Anti-CD25 antibody agents Chemistry; Metallurgy 0 Active
US11919960B2 Anti-CD25 antibody agents Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.